Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 6 Gynecologic 5 Thoracic 1 Sarcoma 1 Head & Neck 1 Gastrointestinal 1 CNS 1

Conditions

Ovarian Carcinosarcoma 1

Interventions

Specimen Handling 14 Magnetic Resonance Spectroscopy 14 Doxorubicin 12 Cyclophosphamide 11 Temozolomide 9 Biopsy 9 Radiation 8 atezolizumab 7 Radiotherapy 7 X-Rays 6 Vincristine 6 Nivolumab 6 Etoposide 6 Bevacizumab 6 pembrolizumab 5 liposomal doxorubicin 5 fludarabine 5 cabozantinib 5 Sirolimus 5 Phantoms, Imaging 5 Irinotecan 5 Immunoglobulin G 5 Ifosfamide 5 Disulfides 5 Nuclear Medicine Department, Hospital 4 temsirolimus 3 palbociclib 3 olaparib 3 fludarabine phosphate 3 Surgical Procedures, Operative 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

niraparib × Sarcoma × 30 days × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡